
A practical look at how choosing the right EU veterinary regulatory pathway can shape cost, market access and speed to first sale when taking a human-health asset into animal health.

How the European veterinary market can offer MedTech founders a faster path to commercial validation by bypassing the human MDR/IVDR regulatory framework.

How entering the veterinary market can help biotech founders accelerate revenue, de-risk human-health development and unlock additional funding opportunities.

EIC Accelerator success requires more than innovation. It requires a compelling, evidence-based case for breakthrough potential, technological excellence, competitive advantage, and market impact.

Winning EIC Accelerator funding requires strong preparation, a multidisciplinary team, and clear evidence of market demand and European impact, with Strategic Healthcare Advisors helping innovators align their strategy with EIC evaluation criteria.

Reaching TRL 6 is a critical EIC Accelerator milestone, and Strategic Healthcare Advisors helps life sciences innovators build sector-specific validation strategies aligned with scientific, regulatory, and funding expectations.

The 2026 EIC Accelerator raises the bar on funding, TRL readiness, and commercial maturity, making a well-aligned funding strategy increasingly important for life sciences innovators.